Sandoz targets 70% price cut for weight-loss drugs in Canada, FT reports
05/08/2025 05:08
Aug 5 (Reuters) - Swiss generic drug manufacturer Sandoz SDZ.S plans to introduce unbranded weight-loss drugs in Canada at up to a 70% discount compared to branded versions when patents begin expiring next year, CEO Richard Saynor told the Financial Times. (Reporting by Bipasha Dey in Bengaluru; Editing by Nivedita Bhattacharjee) ((Bipasha.Dey@thomsonreuters.com;))
Recent news on Sandoz AG
See all newsPfizer dismissed from US states' drug price-fixing lawsuit (updated)
Pfizer dismissed from US states' drug price-fixing lawsuit
Factbox: Major investment pledges at Choose France summit
Press Digest: Financial Times - June 1
Media: Sandoz warns cheap Chinese imports threaten Europe’s antibiotic supply- FT